SITE MAP   |   CONTACT US


First Call Earnings Estimates Summary
Biovail Corporation (ticker symbol: BVF)
Year Ending December
Year
Ending
Q1
Mar
Q2
Jun
Q3
Sep
Q4
Dec
Fisc Yr
Annual
Num
Brok
Cal Yr
Annual
Num
Brok
2014 0 0 0 0 1.82 1 1.82 1
2013 0 0 0 0 1.33 3 1.33 3
2012 0 0 0 0 1.3 5 1.3 5
2011 0 0 0 0 1.04 8 1.04 8
2010 0.31 0.34 0.21 0.24 1.05 6 1.07 7
2009 0.28 0.34 0.32 0.56 1.5 8 1.5 7
2008 0.38 0.37 0.36 0.34 1.44 7 1.44 7
2007 0.58 0.4 0.42 0.45 1.86 14 1.86 14
2006 0.43 0.5 0.83 0.93 2.7 11 2.7 11
2005 0.07 0.34 0.69 0.77 1.87 12 1.87 13
2004 0.18 0.28 0.31 0.58 1.35 13 1.35 13
Consensus Recommendation: 2.1 Consensus 5-yr Growth Rate:4%

Tools

Investment Calculator


Email Alerts

Resources

Q2 2010 Financial Results

Valeant - Biovail Analyst Investor Presentation

Biovail - Valeant Merger Conference Call

Biovail's Product Pipeline

Pimavanserin Schizophrenia Co-Therapy - Phase 2 Data

Aplenzin Prescribing Information

Nitoman Prescribing Information

Xenazine Prescribing Information

Xenazine Medication Guide

Corporate Fact Sheet

IMPORTANT: Income Tax Information for Canadian Resident Shareholders


Download Adobe Acrobat Reader

Events




© 2007 Biovail Corporation - All Rights Reserved (BIO113B0602) Privacy Policy   |   Disclaimers